I wrote about
Alba Therapeutics last year in my series on
Celiac Disease Drug Therapies currently under development. They are currently developing a drug for Celiac Disease called Larazotide acetate (formerly referred to as AT1001). There are 2 clinical trials underway for the drug to test it's effectiveness in treating Celiac Disease.
On Jan 23rd, 2009, the
Baltimore Business Journal reported that Alba has announced layoffs due to the current economical crisis in the US. Twenty-two employees (nearly half of it's workforce) were let go on Jan 7th.
This can't be good news for the company that had high hopes to release the first Celiac Disease drug treatment.
0 comments:
Post a Comment